Lowest-Rated StocksLowest-RatedNYSE:BAX Baxter International (BAX) Stock Price, News & Analysis $24.33 +0.43 (+1.81%) Closing price 10/9/2026 03:59 PM EasternExtended Trading$24.22 -0.11 (-0.44%) As of 10/9/2026 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Baxter International Stock (NYSE:BAX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Baxter International alerts:Sign Up Key Stats Today's Range$23.84▼$24.4750-Day Range$22.79▼$28.3252-Week Range$15.73▼$30.00Volume3.01 million shsAverage Volume7.43 million shsMarket Capitalization$12.58 billionP/E RatioN/ADividend Yield0.16%Price Target$21.73Consensus RatingReduce Company Overview Baxter International Inc. is a global healthcare company that develops and markets products used in hospitals, outpatient facilities and other care settings. Its portfolio includes intravenous solutions and administration sets, infusion pumps, parenteral nutrition products, injectable medicines, surgical products and systems for medication preparation and delivery. The company also provides products and technologies that support anesthesia, critical care, patient monitoring and other hospital workflows. Baxter’s offerings are designed to help healthcare professionals deliver therapies, manage medications and improve the efficiency and safety of patient care. Founded in 1931, Baxter serves healthcare providers and patients in numerous countries worldwide through direct operations, distributors and other commercial partners. The company has historically been headquartered in the Chicago area and has expanded its portfolio through research, development and acquisitions. Its former kidney-care business was separated from Baxter in 2024, while Baxter continues to focus on hospital-based medical products, pharmaceuticals and care-delivery technologies.AI Generated. May Contain Errors. Read More Baxter International Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks23rd Percentile Overall ScoreBAX MarketRank™: Baxter International scored higher than 23% of companies evaluated by MarketBeat, and ranked 797th out of 883 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.9 / 5Analyst RatingReduce Consensus RatingBaxter International has received a consensus rating of Reduce. The company's average rating score is 1.85, and is based on no strong buy ratings, 1 buy rating, 9 hold ratings, and 3 sell ratings.Downside RiskBaxter International has a consensus price target of $21.73, representing about 10.7% downside from its current price of $24.33.Amount of Analyst CoverageBaxter International has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Baxter International's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-1.96% Earnings GrowthEarnings for Baxter International are expected to decrease by -1.96% in the coming year, from $2.04 to $2.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Baxter International is -11.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Baxter International is -11.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioBaxter International has a PEG Ratio of 3.61. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioBaxter International has a P/B Ratio of 2.05. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Baxter International's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.72% of the float of Baxter International has been sold short.Short Interest Ratio / Days to CoverBaxter International has a short interest ratio ("days to cover") of 2.98, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Baxter International has recently increased by 4.91%, indicating that investor sentiment is decreasing. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldBaxter International has a dividend yield of 0.17%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthBaxter International does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Baxter International will have a dividend payout ratio of 2.00% next year. This indicates that Baxter International will be able to sustain or increase its dividend.Read more about Baxter International's dividend. News and Social Media1.9 / 5News Sentiment0.12 News SentimentBaxter International has a news sentiment score of 0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 13 news articles for Baxter International this week, compared to 10 articles on an average week.Search InterestOnly 8 people have searched for BAX on MarketBeat in the last 30 days. This is a decrease of -27% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Baxter International to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Baxter International insiders have not sold or bought any company stock.Percentage Held by Insiders0.17% of the stock of Baxter International is held by insiders.Percentage Held by Institutions90.19% of the stock of Baxter International is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Baxter International's insider trading history. Receive BAX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BAX Stock News HeadlinesBaxter (BAX) Stock May Be 30% Undervalued On Cash FlowOctober 9 at 7:40 PM | finance.yahoo.comBaxter International (NYSE:BAX) Coverage Initiated by Analysts at BarclaysOctober 8 at 2:42 AM | americanbankingnews.comA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, and predictions. He argues a simpler approach can work just as well. His free report, The Simple Path To Success With Options, breaks down a repeatable trade setup, common rookie mistakes, and step-by-step blueprints designed to cut through market noise. No complex charts. No guesswork. Just a straightforward setup anyone can learn.October 10 at 1:00 AM | TradeWins (Ad)Evercore ISI Adjusts Price Target on Baxter International to $32 From $24October 8 at 1:09 AM | marketscreener.comMBarclays initiates coverage of Baxter International at underweightOctober 8 at 1:09 AM | msn.comBaxter to Host Third-Quarter 2026 Financial Results Conference Call for InvestorsOctober 7 at 5:00 PM | businesswire.comCitigroup Has Lowered Expectations for Baxter International (NYSE:BAX) Stock PriceOctober 7 at 1:18 AM | americanbankingnews.comBaxter International (NYSE:BAX) versus Flora Growth (NASDAQ:FLGC) Critical ReviewOctober 6, 2026 | americanbankingnews.comSee More Headlines BAX Stock Analysis - Frequently Asked Questions How have BAX shares performed this year? Baxter International's stock was trading at $19.12 on January 1st, 2026. Since then, BAX shares have increased by 27.3% and is now trading at $24.3320. How were Baxter International's earnings last quarter? Baxter International Inc. (NYSE:BAX) posted its quarterly earnings data on Thursday, July, 30th. The medical instruments supplier reported $0.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.37 by $0.19. The company's revenue was up 5.3% on a year-over-year basis. Read the conference call transcript. Does Baxter International have any subsidiaries? Baxter International subsidiaries include Cheetah Medical, ApaTech Limited, Baxter AO, Baxter Belgium SPRL, Baxter (China) Investment Co. Ltd, Baxter Company Ltd, Baxter Corporation (Canada), and more. Who are Baxter International's major shareholders? Baxter International's top institutional investors include CX Institutional. View institutional ownership trends. How do I buy shares of Baxter International? Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Baxter International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Baxter International investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), ExxonMobil (XOM), Chevron (CVX), JPMorgan Chase & Co. (JPM) and Intel (INTC). Company Calendar Last Earnings7/30/2026Record date for 10/1 Dividend8/28/2026Ex-Dividend for 10/1 Dividend8/28/2026Dividend Payable10/01/2026Today10/10/2026Next Earnings (Estimated)10/29/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1d) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 BAX's financial health is in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:BAX CIK10456 Webwww.baxter.com Phone(224) 948-2000Fax224-948-1813Employees37,500Year Founded1931Price Target and Rating Average Price Target for Baxter International$21.73 High Price Target$27.00 Low Price Target$15.00 Potential Upside/Downside-10.7%Consensus RatingReduce Rating Score (0-4)1.85 Research Coverage13 Analysts Profitability EPS (Trailing Twelve Months)($2.07) Trailing P/E RatioN/A Forward P/E Ratio11.93 P/E Growth3.61Net Income-$957 million Net Margins-9.27% Pretax Margin-4.21% Return on Equity16.57% Return on Assets5.24% Debt Debt-to-Equity Ratio1.39 Current Ratio1.95 Quick Ratio1.32 Sales & Book Value Annual Sales$11.47 billion Price / Sales1.10 Cash Flow$5.79 per share Price / Cash Flow4.20 Book Value$11.87 per share Price / Book2.05Miscellaneous Outstanding Shares516,996,000Free Float516,117,000Market Cap$12.58 billion OptionableOptionable Beta0.65 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NYSE:BAX) was last updated on 10/10/2026 by MarketBeat.com Staff. From Our PartnersThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe only 5 stocks that matterSpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...TradeSmith | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredThis high yielding “gold annuity” is starting to move…Garrett Goggin, a 20+ year gold analyst, has called major moves before: Montage Gold up 2,567%, G2 Goldfields ...Golden Portfolio | SponsoredNew Chip takes minutes, not daysGeorge Gilder believes today's AI data centers could become tomorrow's typewriters - replaced by a single wafe...Eagle Publishing | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredTech expert smashes iPhone with golf clubTwenty years ago, Josh Baylin told Congress the iPhone was coming, three years before it launched. A $1,500 be...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baxter International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Baxter International With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BAX Stock Alerts